Search results for "Assay"

showing 10 items of 2241 documents

Interleukin-5 production by mononuclear cells from aged individuals: implication for autoimmunity.

1999

It is well known that in the elderly a deterioration of immune functions may occur. Particularly, stimulation of T cells from aged individuals leads to different kind and/or size of responses if compared with the responses obtained from T cells from young individuals. At the same time, an increase in prevalence of autoantibodies occurs in elderly. The altered production of certain cytokines might explain this paradox of decreased responsiveness to foreign antigens in the face of an increased response to self-antigens. We and others have suggested that this kind of immune response might depend on an age-associated impairment of Th-1 type function that selectively affects production of cytoki…

AdultMalemedicine.medical_specialtyAgingmedicine.medical_treatmentT-LymphocytesAutoimmunityEnzyme-Linked Immunosorbent AssayBiologymedicine.disease_causeLymphocyte ActivationPeripheral blood mononuclear cellAutoimmunityImmune systemAntigenInternal medicinemedicineHumansInterleukin 5Cells CulturedAgedAged 80 and overB-LymphocytesAutoantibodyImmunosenescenceMiddle AgedImmunoglobulin AEosinophilsEndocrinologyCytokineImmunologyFemaleInterleukin-5Developmental BiologyMechanisms of ageing and development
researchProduct

Protein oxidation in mild essential hypertension

2012

An intensified oxidative stress has been associated with aging and many disease, including essential hypertension (EH) [6, 11, 16]. In EH an increased level of reactive oxygen and nitrogen species (RONS) may impair the bioavailability of nitric oxide (NO), by inducing its accelerated transformation in peroxynitrite [4]. Beside this, many other pathophysiological processes in EH may be influenced by RONS, considering their harmful effects on the structural and functional properties of lipids, proteins and nucleic acids. Some points need to be further investigated, such as the relationship between oxidative stress and the degree of hypertension, and identification of the most useful marker of…

AdultMalemedicine.medical_specialtyAmbulatory blood pressurePhysiologyDiastoleEnzyme-Linked Immunosorbent Assaymedicine.disease_causeProtein oxidationEssential hypertensionLipid peroxidationProtein Carbonylationchemistry.chemical_compoundYoung Adultprotein oxidation essential hypertensionPhysiology (medical)Internal medicinemedicineHumansbusiness.industryHematologyBlood ProteinsMiddle Agedmedicine.diseaseBlood proteinsOxidative StressEndocrinologyBlood pressurechemistryCase-Control StudiesHypertensionFemaleCardiology and Cardiovascular MedicinebusinessOxidation-ReductionOxidative stress
researchProduct

Sulfatide excreting heterozygous carrier of juvenile metachromatic leukodystrophy or asymptomatic patient of adult metachromatic leukodystrophy.

1975

In a family with juvenile metachromatic leukodystrophy (sulfatide lipidosis) 2 patients showed residual arysulfatase A activities of 5--6%. The patients' healthy father was characterized biochemically by a 39% normal activity of leukocyte plus plasma arylsulfatase A. The father was further characterized by a high sulfatide excretion (0.2--0.5 mg/I urine) and, paradoxically, by a normal sulfatide degrading enzyme activity in vitro. This special carrier is suspected to be heterozygous for a) arylsulfatase A deficiency and b) arylsulfatase A (sulfatidase) lability. This presumed additional genetic defect could be the cause of the sulfatide excretion which, in turn, would be a sign of the precl…

AdultMalemedicine.medical_specialtyArylsulfatase AHeterozygoteUrineBiologyAsymptomaticExcretionDrug StabilityInternal medicineGeneticsmedicineHumansChildGenetics (clinical)ArylsulfatasesSulfoglycosphingolipidsLeukodystrophy Metachromaticmedicine.diseaseEnzyme assayIn vitroMetachromatic leukodystrophyEnzyme ActivationEndocrinologybiology.proteinFemalemedicine.symptomSulfatasesArylsulfataseHumangenetik
researchProduct

Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure.

2002

Bacterial endotoxin activity is elevated in patients with decompensated chronic heart failure (HF) and acts as a potent stimulus for immune activation. We sought to determine whether endotoxin, at an activity level seen in vivo (around 0.6 EU/ml), is sufficient to stimulate the secretion of tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha soluble receptor (sTNFR2) in ex vivo whole blood from patients with HF. We studied 15 patients with HF (aged 65 +/- 1.9 years, New York Heart Association class 2.1 +/- 0.3, left ventricular ejection fraction 31 +/- 5%; mean +/- SEM), of whom 5 had cardiac cachexia, and 7 healthy control subjects (59 +/- 5 years, p = NS). Reference endotoxin was added …

AdultMalemedicine.medical_specialtyCachexiaEnzyme-Linked Immunosorbent AssayReceptors Tumor Necrosis FactorCachexiaIn vivoInternal medicinemedicineHumansWhole bloodAgedHeart FailureEjection fractionbusiness.industryTumor Necrosis Factor-alphaVenous bloodMiddle Agedmedicine.diseaseEndotoxinsEndocrinologyHeart failureTumor necrosis factor alphaFemaleCardiology and Cardiovascular MedicinebusinessEx vivoThe American journal of cardiology
researchProduct

Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with sym…

2011

Abstract BACKGROUND Glial fibrillary acidic protein (GFAP) is a biomarker candidate indicative of intracerebral hemorrhage (ICH) in patients with symptoms of acute stroke. GFAP is released rapidly in the presence of expanding intracerebral bleeding, whereas a more gradual release occurs in ischemic stroke. In this study the diagnostic accuracy of plasma GFAP was determined in a prospective multicenter approach. METHODS Within a 1-year recruitment period, patients suspected of having acute (symptom onset <4.5 h before admission) hemispheric stroke were prospectively included into the study in 14 stroke centers in Germany and Switzerland. A blood sample was collected at admission, and …

AdultMalemedicine.medical_specialtyClinical BiochemistryIschemiaBrain IschemiaDiagnosis DifferentialInterquartile rangeInternal medicineGlial Fibrillary Acidic ProteinmedicineHumansIn patientcardiovascular diseasesProspective StudiesProspective cohort studyStrokeAgedCerebral HemorrhageIntracerebral hemorrhageImmunoassayAutoanalysisGlial fibrillary acidic proteinbiologybusiness.industryBiochemistry (medical)Electrochemical TechniquesMiddle Agedmedicine.diseaseSurgeryStrokeAcute DiseaseLuminescent MeasurementsCardiologybiology.proteinBiomarker (medicine)FemalebusinessBiomarkersClinical chemistry
researchProduct

DNA damage in leukocytes and serum nitrite concentration are negatively associated in type 1 diabetes.

2020

Abstract Chronic hyperglycaemia leads to DNA damage in diabetes and might be associated with nitrosative stress. In this study, we aimed at assessing the level of DNA strand breaks in leukocytes, serum nitrite and nitrate in patients with type 1 diabetes and healthy controls and associations of these parameters with diabetes-related outcomes in a prospective study. The level of DNA damage was determined in 71 patients with type 1 diabetes and 57 healthy controls by comet assay and scored with arbitrary units (AU). The chemiluminescence method was used to measure nitrite and nitrate. Clinical information and data on consumption of alcohol, physical activity and smoking were collected. Progre…

AdultMalemedicine.medical_specialtyDNA damageHealth Toxicology and MutagenesisArbitrary unit030204 cardiovascular system & hematologyToxicologyDiabetes Complications03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineDiabetes mellitusGeneticsmedicineLeukocytesHumansProspective StudiesNitriteProspective cohort studyGenetics (clinical)Nitrites030304 developmental biology0303 health sciencesType 1 diabetesbusiness.industrymedicine.diseaseComet assayEndocrinologyDiabetes Mellitus Type 1chemistryRelative riskFemaleComet AssaybusinessDNA DamageMutagenesis
researchProduct

Heterogeneity of Morquio disease.

1986

Further clinical heterogeneity of Morquio disease, mucopolysaccharidosis IV (MPS IV), is delineated by the observation of a 30-year-old man with unusually mild clinical manifestations. He is 156 cm tall, has comparatively mild skeletal abnormalities and fine corneal deposits. Keratosulfaturia is absent. N-Acetylgalactosamine-6-sulfate (GalNAc-6-S) sulfatase (E.C. 3.1.6.-) was markedly reduced in his fibroblasts. The residual enzyme activity exhibited a pH profile comparable to that of patients with the "classical" form of the disorder. From our observation and a review of the literature it is concluded that Morquio disease can be divided in several subgroups: besides the severe ("classical"…

AdultMalemedicine.medical_specialtyDiseaseMucopolysaccharidosis Type IVAInternal medicineGeneticsmedicineHumansGenetics (clinical)chemistry.chemical_classificationbiologybusiness.industrySulfataseGenetic VariationMucopolysaccharidosis IVFibroblastsHydrogen-Ion Concentrationbeta-GalactosidasePhenotypeEnzyme assayChondroitinsulfatasesEnzymeEndocrinologyPhenotypechemistrybiology.proteinMucopolysaccharidosis IVbusinessNeuraminidaseClinical genetics
researchProduct

Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity.

2014

Abstract Background Skeletal muscles produce irisin. Growing controversy exists on the association between this myokine and chronic disease risk. On the basis of the potential protective effects that irisin could exert on both vascular function and skeletal muscle mass, we hypothesized that an elevated level of this molecule may contribute to successful aging. Methods Serum irisin levels were measured using enzyme-linked immunosorbent assay in disease-free centenarians, young healthy controls, and patients with precocious acute myocardial infarction. Results We found the highest levels of serum irisin in disease-free centenarians (35.3 ± 5.5 ng/mL) compared with young healthy controls (20.7…

AdultMalemedicine.medical_specialtyElevated levelmedia_common.quotation_subjectLongevityAncianoMyocardial InfarctionEnzyme-Linked Immunosorbent AssayInternal medicineMyokinemedicineHumansMyocardial infarctionAncianos - Condición físicaAncianos - CardiologíaIrisinamedia_commonAged 80 and overLife spanbusiness.industryLongevityCase-control studyGeneral Medicinemedicine.diseaseHealthy VolunteersFibronectinsEndocrinologyChronic diseaseLogistic ModelsCase-Control StudiesMultivariate AnalysisFemaleLongevidad extremabusinessVascular functionBiomarkers
researchProduct

Serum levels of type III procollagen peptide in diabetes mellitus.

1989

Serum levels of type III procollagen peptide (P-III-P) were investigated in 19 patients with type 1 (insulin-dependent) and in 48 (25 orally treated, 23 insulinized) patients with type 2 (non insulin-dependent) diabetes mellitus. Among patients with type 2 diabetes, 16 orally treated and 14 insulin-treated subjects had macrovascular complications. P-III-P levels were not correlated with the duration of diabetes and with glucose control, nor were there any significant sex and age differences in the levels. P-III-P values were significantly higher in the sera of insulin-treated non insulin-dependent diabetic patients with macroangiopathy. These high values (18.5 +/- 10.8 ng/ml) were in contra…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryType 2 diabetesBiochemistryPathogenesisEndocrinologyInternal medicineDiabetes mellitusmedicineDiabetes MellitusHumansSensitizationPancreatic hormoneAgedbusiness.industryInsulinBiochemistry (medical)RadioimmunoassayGeneral MedicineMiddle Agedmedicine.diseaseProcollagen peptidasemedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2FemalebusinessProcollagenHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
researchProduct

Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease.

2005

Background Monocyte chemoattractant protein-1 (MCP-1) is involved in the recruitment of monocytes into the arterial vessel wall as one of the major events leading to atherosclerotic vascular diseases, such as coronary artery disease (CAD). Methods and Results The study group comprised 263 volunteers aged between 18 and 85 years who were admitted to hospital or clinic for scheduled invasive and non-invasive diagnostic procedures. MCP-1 serum levels were determined using a sandwich-enzyme-linked immunosorbent assay. In each patient, the coronary risk factors (CRF), such as hypertension, high cholesterol, diabetes mellitus, obesity, positive family history, and smoking were evaluated. Low-dens…

AdultMalemedicine.medical_specialtyEndotheliumAdolescentEnzyme-Linked Immunosorbent AssayCoronary Artery DiseaseCoronary AngiographyHigh cholesterolCoronary artery diseaseEndothelial activationRisk FactorsInternal medicineDiabetes mellitusMedicineHumansChemokine CCL2Agedbusiness.industryGeneral MedicineMiddle AgedIntercellular adhesion moleculemedicine.diseaseAtherosclerosismedicine.anatomical_structureCardiologyFemaleEndothelium VascularCardiology and Cardiovascular MedicinebusinessBiomarkersArteryLipoproteinCirculation journal : official journal of the Japanese Circulation Society
researchProduct